416 related articles for article (PubMed ID: 16728988)
1. Are we lowering LDL cholesterol sufficiently?
Barter P; Rye KA
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
[No Abstract] [Full Text] [Related]
2. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
Olsson AG
Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
[No Abstract] [Full Text] [Related]
3. Statins and hypertension.
Cífková R; Nilsson PM
J Hypertens; 2009 Mar; 27(3):662-5. PubMed ID: 19262236
[No Abstract] [Full Text] [Related]
4. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
5. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Toth PP; Davidson MH
J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
[No Abstract] [Full Text] [Related]
6. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
7. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
Chodick G; Shalev V
Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
[No Abstract] [Full Text] [Related]
8. An update to the National Cholesterol Education Program: 2009 suggested changes.
Medina-Ruíz A
Bol Asoc Med P R; 2009; 101(4):30-3. PubMed ID: 20853557
[TBL] [Abstract][Full Text] [Related]
9. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.
Thompson GR; Catapano A; Saheb S; Atassi-Dumont M; Barbir M; Eriksson M; Paulweber B; Sijbrands E; Stalenhoef AF; Parhofer KG
Curr Opin Lipidol; 2010 Dec; 21(6):492-8. PubMed ID: 20935563
[TBL] [Abstract][Full Text] [Related]
10. Government cholesterol recommendations questioned.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Oct; 15(20):9-10, 12. PubMed ID: 15505935
[No Abstract] [Full Text] [Related]
11. Lowering cholesterol: is there a limit?
Harv Mens Health Watch; 2007 May; 11(10):5-6, 8. PubMed ID: 17514824
[No Abstract] [Full Text] [Related]
12. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Couzin J
Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
[No Abstract] [Full Text] [Related]
13. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
[No Abstract] [Full Text] [Related]
14. Don't trust an LDL over 70?
Aronow WS
Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
[No Abstract] [Full Text] [Related]
15. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
16. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
17. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
[No Abstract] [Full Text] [Related]
18. [Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
MMW Fortschr Med; 2006 Nov; 148(48):54-5. PubMed ID: 17615773
[No Abstract] [Full Text] [Related]
19. In brief: Zetia and Vytorin: the ENHANCE study.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
[No Abstract] [Full Text] [Related]
20. Drug insight: Statin use in the elderly.
Raffel OC; White HD
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
